Tag Archives: 3Rs

EU Directive ‘cannot be implemented in isolation’ Brussels roundtable agrees

At a roundtable discussion on the use of animals in scientific research there is overwhelming agreement that Europe has appropriate and detailed legislation regulating the use of animals in scientific research, that adapts to and encourages scientific progress.

Conclusions also show that successful implementation of the Directive is a shared responsibility. The round table identified opportunities to join forces and work together, as the Directive 2010/63/EU cannot be successfully implemented by organisations or individuals working in isolation.

At the meeting in Brussels, representatives from the diverse sectors within the biomedical community (academia, industry, research organisations, medical charities, etc.) and policy-makers discuss the recommendations of the European Commission review report of the Directive 2010/63/EU on the protection of animals used for scientific purposes.

The objective of the roundtable was to  inform policy discussion in EU institutions and to identify recommendations for the users’ community on this basis. Topics under discussion were: the implementation of the Directive; improving openness and transparency; ideas for further areas to be tackled. Continue reading

Primate poposal by Netherlands government ‘will severely limit progress on biomedical research’.

EARA has responded to a call by the Dutch Science Minister for the Biomedical Primate Research Centre (BPRC), in the Netherlands, an EARA member, to draw up a proposal, by the beginning of next year, to reduce the number of experiments with no-human primates (NHP) by up to 40%.

Ahead of a debate, which took place in the Netherlands House of Representatives earlier this month, EARA wrote to Ingrid van Engelshoven, Minister of Education, Culture and Science and Carola Schouten, Minister of Agriculture, Nature and Food Quality, urging them not to set an artificial limit on the number of NHP used in research.

The letter, written by EARA, said that any reduction was “highly likely to severely limit the progress that can be made in both fundamental research and the development of innovative medicines and treatments for life-threatening diseases and infectious disease control”.

Currently the main areas of primate study are infectious diseases, neuroscience and fertility and foetal research. Primates are an important model for the development of vaccines and treatments for HIV/AIDS, Ebola, Zika and malaria and for investigations into treatments for conditions ranging from Alzheimer’s disease to Schizophrenia. They are also used in safety testing for new medicines and vaccines. Continue reading

European scientific community welcomes EU review of the Directive for the protection of animals used for research

PRESS RELEASE

LONDON, UK – 10 November, 2017

The European scientific community supports the view of the EU Commission, that the Directive on the protection of animals used in biomedical research is bringing significant benefits in animal welfare and a sound foundation for future best practice in the sector.

The European Animal Research Association (EARA), which represents more than 60 organisations across Europe in the biomedical research sector, has welcomed the Commission report, published today. The report reviews the requirements of Directive 2010/63/EU – all uses of live animals for research or education and testing must be carried out in compliance with the Directive.

In particular, the EU recognised that measures to improve transparency to the general public on the performance of research establishments in the areas of animal use and welfare are starting to have an effect. Requirements to publish non-technical summaries of the objectives and benefits of research projects, as well as annual statistical data, are also seen to have greatly improved openness in Member States. Continue reading

Environmental factors can improve reproducibility

At a meeting on improving mouse models of disease held last week at the Wellcome Genome Campus in Cambridge, scientists and technicians came together to discuss opportunities to improve the reproducibility of research results obtained using mouse models. Nature reported on some of the environmental and biological factors that affect mouse studies.

Continue reading

European Partnership for Alternative Approaches to Animal Testing: 10 years of promoting development and acceptance of alternatives

The European Directive 2010/63 that protects animals required for scientific purposes was enforced in Member states in 2012. The Directive introduced the 3R principles of replacement, reduction and refinement of animal procedures into regulation. The scientific community has recognised the Directive as the world’s most progressive and stringent framework seeking to ensure high animal welfare standards while encouraging the development of alternative methods. As a result of this new legislation, there has been a growing interest in the development and implementation of alternative methods. One initiative pursuing this goal is the European Partnership for Alternative Approaches to Animal Testing (EPAA). Continue reading

Panel Discussion on the effectiveness and reliability of alternative methods used for regulatory purposes

On December 1 of last year the European Partnership for Alternative Approaches to Animal Testing (EPAA) celebrated its tenth anniversary with a conference in the European Parliament. As part of the conference Julie Girling, Member of the European Parliament and EPAA stakeholder, chaired a roundtable to discuss challenges in developing alternative methods seeking to replace, reduce and refine animal procedures. Around the table were Maurice Whelan from the European Commission Directorate General Joint Research Centre, Erwin Roggen from Novozymes, Sonja Beken from the European Medicines Agency (EMA) and Joop de Knecht from the Organisation for Economic Co-operation and Development (OECD). Continue reading